Physician profile

Bryce Elliot Epstein

Physical Medicine & Rehabilitation · Aventura, FL

NPI 1609960814

$4,065.51

in general payments reported to CMS, 2019-2025

39 companies · $1,080 in 2025

The $1,080 reported for 2025 was more than what 88% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).

See the full distribution for Physical Medicine & Rehabilitation

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,871.90

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $922.41 2022-2025
Ani Pharmaceuticals, INC. $282.96 2023-2025 Purified Cortrophin Gel
Amgen INC. $277.67 2021-2024 Enbrel
Mallinckrodt Hospital Products INC. $275.97 2022-2025 Acthar
Radius Health, INC. $257.66 2022-2025 Tymlos
Aurinia Pharma U.S., INC. $250.20 2022-2025 Lupkynis
Lilly USA, LLC $175.24 2022-2024 Taltz
Takeda Pharmaceuticals U.S.A., INC. $141.69 2023-2025 Hyqvia, Cuvitru
Medtronic USA, INC. $126.33 2019
Ucb, INC. $125.54 2024-2025 Bimzelx
Electronic Waveform Lab, INC. $111.66 2019-2025
Fresenius Kabi USA, LLC $111.62 2023-2025
Alvogen INC $83.71 2022-2023 Teriparatide
Depuy Synthes Sales INC. $79.44 2024 Monovisc
Janssen Biotech, INC. $77.19 2023-2025 Tremfya, Simponi Aria, Remicade
Show all 39 companies
CompanyGeneral paymentsYearsTop products
Collegium Pharmaceutical, INC. $65.40 2019-2021
Genzyme Corporation $63.69 2023-2025
Zimmer Biomet Holdings, INC. $63.16 2019-2021
Astrazeneca Pharmaceuticals LP $50.27 2023-2024 Saphnelo
Boston Scientific Corporation $47.87 2023
Organon LLC $40.32 2023 Hadlima, Renflexis
Octapharma USA, INC. $37.86 2022-2023 Octagam Immune Globulin (Human)
Tersera Therapeutics LLC $35.59 2025 Quzyttir
Bioventus LLC $33.04 2019-2021
Redhill Biopharma INC. $32.45 2021
Embody, INC. $27.29 2021
Csl Behring $26.59 2024 Kcentra
Pacira Therapeutics, INC. $25.27 2020
Scilex Pharmaceuticals INC. $24.34 2024
Novartis Pharmaceuticals Corporation $23.24 2022
Pharming Healthcare, INC. $22.21 2025 Ruconest
Vericel Corporation $21.72 2021
Boehringer Ingelheim Pharmaceuticals, INC. $21.03 2022
Sandoz INC. $20.97 2025 Jubbonti
Horizon Therapeutics Plc $20.15 2020
Endo Pharmaceuticals INC. $19.26 2019
Ultragenyx Pharmaceutical INC. $15.24 2023 Crysvita
Baxter Healthcare $15.05 2019
Sentynl Therapeutics, INC. $14.21 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Bryce Elliot Epstein

$4,065.51

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbvie INC.
Context
The $1,080 reported for 2025 was more than what 88% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).

https://glasscript.com/doctor/164220/bryce-elliot-epstein

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.